TY - JOUR
T1 - Anabolic androgenic steroid abuse in the United Kingdom
T2 - An update
AU - Mullen, Carrie
AU - Whalley, Benjamin J.
AU - Schifano, Fabrizio
AU - Baker, Julien S.
N1 - Publisher Copyright:
© 2020 The British Pharmacological Society
PY - 2020/5/1
Y1 - 2020/5/1
N2 - Anabolic androgenic steroids (AASs) are prescribed for medical conditions related to low testosterone. Abuse of AASs has surged as they become recognised as potent image enhancement drugs. The primary goal of most abusers is to obtain a more attractive outward appearance. Abuse is complex. There are a vast range of AAS substances illegally available, the nature of their true composition is difficult to evaluate. Users follow dosing patterns which incorporate a number of different AASs, in addition to other pharmaceutical substances believed to complement the desired physical effects or manage unwanted effects. Animal work and medical case reports suggest potential to cause serious hepatotoxicity, plus possible neurotoxicity, nephrotoxicity and damage to the cardiovascular and reproductive systems. As the long-term AASs users reach maturity, further controlled experimentation, with larger sample sizes, is required. Data gathering should be directed towards the most vulnerable group of AAS users, females and adolescent boys.
AB - Anabolic androgenic steroids (AASs) are prescribed for medical conditions related to low testosterone. Abuse of AASs has surged as they become recognised as potent image enhancement drugs. The primary goal of most abusers is to obtain a more attractive outward appearance. Abuse is complex. There are a vast range of AAS substances illegally available, the nature of their true composition is difficult to evaluate. Users follow dosing patterns which incorporate a number of different AASs, in addition to other pharmaceutical substances believed to complement the desired physical effects or manage unwanted effects. Animal work and medical case reports suggest potential to cause serious hepatotoxicity, plus possible neurotoxicity, nephrotoxicity and damage to the cardiovascular and reproductive systems. As the long-term AASs users reach maturity, further controlled experimentation, with larger sample sizes, is required. Data gathering should be directed towards the most vulnerable group of AAS users, females and adolescent boys.
UR - http://www.scopus.com/inward/record.url?scp=85081619029&partnerID=8YFLogxK
U2 - 10.1111/bph.14995
DO - 10.1111/bph.14995
M3 - Review article
C2 - 31989581
AN - SCOPUS:85081619029
SN - 0007-1188
VL - 177
SP - 2180
EP - 2198
JO - British Journal of Pharmacology
JF - British Journal of Pharmacology
IS - 10
ER -